Cardeas Pharma

Developer of inhaled antibiotics for DR gram negative infections

placeSeattle, Washington, United States calendar_todayFounded 2010 groups2 employees language cardeaspharma.com

Registered entities

Innovation

4 patent families (4 granted) — focus: Human necessities; filing pace dormant. Cited 535 times.

YearFilings
20132
20143
20153
20163
20173
20192

Investor mix

6 investors on record; lead investors include HIG BioHealth Partners.

Investor typeCountShare
Venture capital467%
Other / undisclosed233%
Coming soon